The development of neural subtypes in the dorsoventral (DV) axis of the vertebrate central nervous system (CNS) involves the integration of signalling pathways coupled with the combinatorial expression of homeodomain transcription factors. Previous studies have implicated a role for retinoic acid in the specification of a subtype of motor neurons (MN) and in the patterning of a group of interneurons within the ventral spinal cord. In this study, we use the vitamin A-deficient (VAD) quail model to further investigate the role of retinoids in the patterning of the neural tube. Using genetic markers specific to neuronal cell populations, we demonstrate that in the absence of retinoic acid, there is a disruption to the molecular mechanisms associated with the dorsoventral patterning of the spinal cord. In particular, we observe an uneven dorsal expansion of ventral-specific genes, accompanied by a reduction in the domain of roof plate and dorsal patterning genes, both of which are rescued upon addition of retinoids during development. In addition, there is a loss of V1 interneuron-specific gene expression and a decrease in the ventricular zone expression of motor neuron patterning genes. Interestingly, these effects are localised to the rostral half of the spinal cord, indicating that RA is integrated in both anteroposterior (AP) and dorsoventral patterning processes. Using differential display techniques, we have isolated 27 retinoic acid-regulated genes within the spinal cord that together reveal several interesting potential biological functions for retinoids within the avian neural tube. In summary, we propose that retinoids have an essential role in the patterning of the dorsoventral axis of the spinal cord, and are also required for the correct integration of anteroposterior patterning signals with dorsoventral determinants in the rostral spinal cord.
Introduction
Development of the central nervous system (CNS) involves the specification of distinct classes of neurons at defined locations within the neural tube (Lumsden and Krumlauf, 1996; Tanabe and Jessell, 1996) . Recent studies have identified several mechanisms mediated by extracellular signals that instruct the differentiation of cell types along the dorsoventral (DV) and anteroposterior (AP) axes of the neural tube (reviewed in Jessell, 2000; Lee and Pfaff, 2001 ).
In the DV axis, current theory suggests that the generation of neuronal populations involves opposing gradients of morphogens. Sonic hedgehog protein (SHH), generated ventrally in the notochord and floor plate, acts in a concentrationdependent manner to induce several classes of ventral interneuron progenitors (V0 -V3) as well as help specify the identity of motor neuron (MN) progenitors (Ericson et al., 1995 (Ericson et al., , 1997a . It does this by regulating the pattern of expression of a set of homeodomain (HD) and basic helixloop -helix (bHLH) transcription factors that are categorised into two major groups based on their modulation by SHH: class I proteins that are repressed by SHH and class II proteins that are activated by SHH (Briscoe et al., 1999 Jessell, 2000) . The combinatorial expression of these two classes of HD proteins serves to establish individual neural progenitor domains, the boundaries of which become sharpened through selective cross-regulatory interactions (Briscoe et al., 1999; Muhr et al., 2001; Pierani et al., 2001; Vallstedt et al., 2001) . In the dorsal spinal cord, the expression and inductive activities of bone morphogenetic proteins (BMPs) in the over-lying ectoderm, and roof plate provides an opposing gradient to SHH and plays a major part in the mechanisms defining the dorsal (dl1 -dl6) neuronal progenitor cell populations (reviewed in Helms and Johnson, 2003; Lee and Jessell, 1999; Liem et al., 2000; Nguyen et al., 2000) .
In addition to these signalling molecules, retinoic acid (RA) has been implicated in two aspects of spinal cord DV patterning. Firstly, in the induction of a subset of ventral interneurons (Pierani et al., 1999) and secondly, in the specification of MN subtypes (Sockanathan and Jessell, 1998) . Evidence for the role of RA in the induction of interneurons comes from experiments in which naive neural plate tissue cultured in the presence of retinol (the metabolic precursor of RA) results in the appearance of subsets of interneurons, characterised by the expression of the homeobox genes Dbx1, Dbx2, Evx1, Evx2 and En (Pierani et al., 1999) . A later role for retinoid signalling in MN patterning was initially indicated by the expression of the RA-synthesising enzyme Raldh2 in the MNs at limb levels (Berggren et al., 1999; Niederreither et al., 1997) . Viral misexpression of Raldh2 at thoracic non-limb levels resulted in the formation of ectopic lateral motor column neurons (LMCs), which are usually found exclusively at limb levels. Furthermore, the specific LMCs that were generated by viral misexpression did not arise from the Raldh2-expressing cells, but instead from adjacent cells that migrated through the region of ectopic Raldh2 expression to form the lateral LMCs. Such data indicate the existence of a paracrine inductive mechanism for the patterning of subtypes of MNs, whereby one cell generates RA from RALDH2, and an adjacent cell is induced to form a specific type of MN (Sockanathan and Jessell, 1998) .
To further investigate the role of RA in the patterning of the DV spinal cord, we have examined the effects of an absence of retinoids using the vitamin A-deficient (VAD) quail model. We show that the expression domains of several key patterning genes associated with induction and specification of neuronal DV progenitor populations are disrupted in the absence of RA, such that there is an abnormal expansion of ventral-specific genes into dorsal domains. This is combined with a dorsal shift and reduction in the expression of dorsal-specific genes and an apparent loss of the V1 interneuron population. We also show that these effects are generally restricted to the anterior spinal cord region in the VAD embryo and that the complete rescue of these gene disruption phenotypes can be observed upon addition of RA to VAD embryos during development.
In addition, to advance our understanding of the pathways through which RA acts in the spinal cord, we have performed a differential display screen comparing gene expression profiles between normal and VAD quail spinal cords. We identified 27 RA-regulated genes, the majority of which were up-regulated in the absence of RA. Also, several interesting pathways of RA action were revealed amongst known functionally interconnected molecules. Together, these data demonstrate a vital role for RA signalling in the regulation of patterning mechanisms and development within the spinal cord and provide evidence linking RA to the integration of patterning cues between the DV and AP axes within the developing CNS.
Materials and methods

Embryo preparation and staging
Fertilized quail eggs were incubated at 38jC until the required developmental stages. Incubation times and staging were as per Hamburger and Hamilton (1951) and the use of equivalent developmental stages was confirmed by counting somite numbers. In all of the work described here, embryos at stages 18 -20 were used. VAD embryos were obtained from Japanese quail (Coturnix coturnix japonica) hens fed on a semi-purified diet containing 10 mg/kg all-trans-retinoic acid as the only source of vitamin A. Normal quail eggs were obtained from a local supplier. Embryos for whole mount in situ hybridisation were fixed in 4% PFA/PBS and stored at 4jC for no longer than 1 month.
Rescue experiments
Rescue experiments were carried out by cutting a window in the shell of the egg incubated on its side and injecting 10 Al of a retinol solution. The retinol solution consists of 200 Al of 1:9 calligraphy ink/tyrodes solution, 400 Al of 15% egg extract in tyrodes solution and 1 Al of 600 ng/Al all-trans retinol (atROH) diluted in 100% ethanol giving a final retinol concentration of 1 ng/Al. VAD embryos were injected with the retinol solution and to ensure that the retinol injection did not have any effects other than to replace the missing retinoids in the VAD embryos, normal quail control embryos were injected with the same retinol injection solution as VAD experimental animals. In addition, to verify that the components of the carrier solution mixture were not having any active biological effect in the rescue experiment, VAD control embryos were injected with the carrier solution (from which retinoids were absent). Injections were carried out on somite-staged embryos aged between stages 5 and 8. Operated eggs were sealed after injection with tape and returned to an incubator at 38jC and allowed to develop until stages 18 -20. Embryos were fixed in 4% PFA/PBS and stored at 4jC for further analysis.
Molecular analyses
Whole mount in situ hybridisation with digoxigenin and fluorescein-labelled riboprobes was performed as described by Wilkinson (1992) , using probes from templates kindly provided by A. Blentic (Raldh2), A. Graham, T. Jessell (MNR2), C. Logan (Engrailed-1), I. Mason, J. Rubenstein (Nkx6.1), and E. Swindell (Cyp26A1) .
Embryos analysed by sectioning were embedded in 20% gelatin and fixed in 4% PFA/PBS for at least 2 days. Sections were cut at 40 Am on a vibratome and mounted in 90% glycerol/PBS before being photographed using a digital camera.
Differential display
Differential display reverse transcription PCR (DD-RT-PCR) was employed to profile the array of the genes expressed in normal and VAD spinal cords of quail embryos at stages 18 -20 of development. The spinal cords of 78 normal and 96 VAD embryos were mechanically and proteolytically separated from the associated mesoderm and ectoderm as described previously . DD-RT-PCR was performed using the Hieroglyph mRNA profile kit and protocol (Beckman Coultier, USA) with modifications as described in earlier studies Medhurst et al., 2000) . Clones were generated using the following oligodT (AP) and arbitrary (ARP) primer combinations: C, I and M: AP1/ARP1; B and D: AP3/ARP1; E and F: AP3/ARP3; G and H: AP5/ARP1; J, K, L, N, O, P, Q, R, S and T: AP1/ARP4; U and V: AP2/ ARP4 and A, W, X, Y, Z and g: AP3/ARP4 (see manufacturer's data for sequences). The gel profile of each differentially expressed cDNA was confirmed before subcloning by performing an identical DD-RT-PCR on different normal and VAD RNA pools. Each repeated and re-amplified differentially expressed band was cloned independently at least eight times and sequenced at the MRC Centre for Developmental Neurobiology sequencing facility (see also Medhurst et al., 2000) .
Results
Although the initial establishment of the broad DV spinal cord pattern occurs early in avian development, the molecular triggers responsible for the specification of the more refined patterns of neural progenitor groups and the consequent differentiation cues appear to occur later, at approximately stage 18 of development onwards (Jessell, 2000) . Therefore, in all of the work described here, comparative analyses between normal and VADs were made on embryos between stages 18 and 20 of development. To make fair comparison and ensure similar analyses of the DV distribution of gene expression patterns in the spinal cord, transverse sections were consistently taken at the level of the forelimb along the AP axis. This AP level was chosen as it provides the full range of neuronal populations associated with the spinal cord DV pattern, including those MNs associated with the brachial eminence of the limb region. This decision was also based on data from other previous studies indicating the RA regulation of patterning processes occurs specifically in the hindbrain and anterior spinal cord regions of the neuraxis (Dupe and Lumsden, 2001; Gale et al., 1999; Liu et al., 2001; Maden et al., 1996) .
Morphology of the VAD spinal cord
Studies investigating the effects of RA deprivation on the overall morphological and cellular arrangements within the spinal cord of the VAD embryo are presented in detail elsewhere (Wilson et al., 2003) . The VAD embryo at stage 18 exhibits a wider floor plate region and thicker roof plate, accompanied by alterations in the arrangement of actin filaments and junctional complexes leading to a disrupted lumenal shape in the central canal of the spinal cord. There is a reduction in the overall cellularity of the VAD spinal cord, a finding that is supported by a decrease in cell proliferation, but the levels of apoptotic cell death are not elevated at the stages tested (Wilson et al., 2003) . Furthermore, the process of neural tube closure appears normal in the VAD embryo, as they do not display any signs of spina bifida or exencephaly.
Expression of RA-synthesising and -catabolising enzymes in the normal and VAD spinal cord
The expression of Raldh2 is localised to the roof plate and MN regions of the spinal cord in the normal embryo as previously described (Fig. 1A ) (Berggren et al., 1999; Blentic et al., 2003) . In the VAD embryo, expression of Raldh2 is lost from the MN domain, but persists in the roof plate region (n = 6; Fig. 1B ). Expression of Cyp26A1 in the normal embryo is located to the dorsal third of the spinal cord, with expression being absent from the roof plate region (Fig. 1C) , consistent with previous work (Swindell et al., 1999) . In the VAD embryo, Cyp26A1 expression is absent from the entire DV axis of the spinal cord (n = 10; Fig. 1D ). This reveals a differential regulation of Raldh2 between the MNs and the roof plate and that in the absence of RA Cyp26A1 in the dorsal neural tube fails to be upregulated, a finding consistent with the presence of an RAresponsive element (RARE) in the upstream regulatory region of this gene (Ray et al., 1997) .
Ventral patterning genes in the normal and VAD spinal cord
The signalling protein SHH has a pivotal role in the determination of ventral interneurons and MN cell groups in the ventral neural tube and is restricted to the floor plate and notochord regions of the spinal cord in the normal embryo ( Fig. 1E) (Ericson et al., 1997a; Jessell, 2000; Patten and Placzek, 2000) . We found the expression of Shh in the VAD embryo was no longer restricted to the floor plate region of the neural tube, but was instead expanded in a dorsal direction into prospective V3 interneuron and MN regions of the ventral spinal cord (n = 6; Fig. 1F ). These results suggest a repressive role for RA in the control of Shh expression in the floor plate and are supported by a corresponding dorsal expansion of the SHH-regulated ventral midline marker HNF3-h (data not shown).
To investigate the possible downstream consequences of an expansion of the Shh domain, several other ventral patterning genes were used as markers. The expression of Nkx6.1, a marker of V3, V2 interneurons and MNs in the normal embryo ( Fig. 1G) (Pabst et al., 1998; Qiu et al., 1998) was also expanded in a dorsal direction into presumptive intermediate spinal cord regions associated with V1, V0 and dorsal interneuron populations (n = 10; Fig.  1H ). In contrast to these results, the expression of Pax6, which is believed to be involved in establishing the neural progenitor cell domains of MNs, V2 and V1 interneurons in response to graded SHH signalling (Ericson et al., 1997b; Sun et al., 1998; Takahashi and Osumi, 2002) , is expressed in the ventral intermediate and dorsal neural tube in the normal embryo ( Fig. 1I ) but is dramatically downregulated in the VAD spinal cord (n = 5; Fig. 1J ). Such a downregulation may suggest the existence of an SHH-independent pathway of Pax6 regulation involving RA. . Normal floor plate expression of Shh (E) and ventral expression of Nkx6.1 (G) is expanded in a dorsal direction in the VAD embryos (arrows in F, H), whereas normal Pax6 (I) and V0 expressions of En-1 (K) are both downregulated/absent in the VAD (arrows in J, L). MN expression of Isl-1 and MNR2 in the normal (M, O) becomes decreased both in intensity and region in the VAD embryo (arrows in N, P). Normal roof plate expression of Bmp4 (Q), Bmp7 (S) and Msx2 (U) is decreased in the most ventral cells in the VAD embryo (arrows in R, T, V). Likewise, the normal dorsal expression of Wnt1 (X) and Wnt3a (Z) is downregulated in the VAD embryos (arrows in Y, AV) and there is a dramatic loss of expression from the normal dorsal half expression with Pax3 and Pax7 (BV, DV) in the VAD embryos (arrows in CV, EV). rp, roof plate; fp, floor plate; dIN, dorsal interneurons; vIN, ventral interneurons; mn, motor neurons.
To examine the effect of an absence of RA on the V1 interneuron population, we used the expression of the transcription factor Engrailed-1 (En-1) (Fig. 1K) (Matise and Joyner, 1997; Saueressig et al., 1999) . Our studies revealed a loss of En-1 expression in the VAD embryo (n = 3; Fig. 1L ), possibly indicating a loss of the V1 population of neurons from this domain of the spinal cord.
In summary, the effect of RA-deprivation on the expression of patterning genes in the ventral spinal cord results in a dorsal expansion of Shh and Nkx6.1 and a downregulation and loss of Pax6 and En-1 expression. This suggests a selective role for RA in the regulation of the spatial restriction of genes expressed in the floor plate and V3, MN and V2 neuronal populations and also in the positive regulation of genes expressed more dorsally in the ventral spinal cord in V1 and V0 cell groups.
Motor neuron patterning genes in the normal and VAD spinal cord
Given the previously proposed role for RA in the determination of MN subtype via the expression of Raldh2 (Berggren et al., 1999; Sockanathan and Jessell, 1998) , we analysed the effect of RA deprivation on the expression of MN genes. We used Islet-1 (Isl-1) which has been shown to be required for the generation of all spinal MNs (Pfaff et al., 1996) , and MNR2, which is believed to function initially in specifying MN identity and then later in regulating subtype identity (Tanabe et al., 1998; William et al., 2003) .
We found that both Isl-1 and MNR2 are expressed in the broad MN domain of the spinal cord in normal embryos (Figs. 1M, O) . However, in the VAD embryo, the expression of both Isl-1 (n = 5; Fig. 1N ) and MNR2 (n = 5; Fig. 1P ) were downregulated with respect to the intensity of expression, and also decreased in the medial domain of expression.
Dorsal patterning genes in the normal and VAD spinal cord
Next, we investigated the effect of RA deficiency on the expression of patterning genes associated with the dorsal spinal cord. To begin, we looked at the expression of Bmp4 and Bmp7 (Lee and Jessell, 1999) . The expression of Bmp4 is restricted to the roof plate region of the dorsal neural tube in the normal embryo (Fig. 1Q) , whereas expression of Bmp7 is localised to a broader domain in the dorsal half of the spinal cord, with the highest levels of expression being in the roof plate region (Fig. 1S) . However, in the VAD embryos, expression of both Bmp4 (n = 5; Fig. 1R ) and Bmp7 (n = 5; Fig. 1T ) display a decrease in the ventralmost regions of expression. The same phenotype is observed with the expression of Msx2, a BMP-regulated homeobox gene expressed in the roof plate of the normal embryo (Fig. 1U ) that displays strong downregulation in the VAD embryo (n = 6; Fig. 1V) . Interestingly, the expression domains of the signalling molecules Wnt1 and Wnt3a whose expression is in the roof plate and most dorsal interneurons in the normal embryos (Figs. 1X and Z, respectively) are also disrupted in the VAD embryos. Wnt1 in the VAD embryo (n = 4; Fig. 1Y ) exhibits ventral loss of expression and a downregulation in the intensity of the remaining signal, whereas Wnt3a (n = 4; Fig. 1AV ) shows less shrinkage in the expression domain but a similar degree of reduced intensity to Wnt1.
To provide additional information on the more ventral populations of dorsal neuron groups, we observed the expression patterns of the paired-box HD transcription factors, Pax3 and Pax7. In the normal embryo, the expression of both Pax3 (Fig. 1BV) and Pax7 (Fig. 1DV) are in the dorsal half of the spinal cord. In the VAD embryos, however, there was a dramatic loss of both Pax3 (n = 35; Fig. 1CV ) and Pax7 (n = 25; Fig. 1EV ) expression throughout the entire dorsal half of the neural tube. Therefore, in summary, several of the genes expressed in the dorsal spinal cord exhibit a downregulation or loss of expression in the absence of RA.
Collectively, the general DV phenotype emerging from the VAD embryo reveals a dorsal expansion of ventral genes, accompanied by, and possibly resulting in, shrinkage Fig. 3 . Rescue of the normal DV gene expression domains in the VAD spinal cord. Expression of Nkx6.1 in the normal control embryo is restricted to regular ventral domains (A, B), whilst in the VAD control embryo expression is expanded in a dorsal direction as predicted (C, arrows in D). In the VAD rescue embryo Nkx6.1 expression resumes to normal ventral domains (E, arrows in F). Dorsal Pax3 expression remains regular in the normal control embryo (G, H) but is abolished in the VAD control embryo as found previously (I, arrows in J). However, expression of Pax3 returns to normal domains in the VAD rescue embryo spinal cord (K, arrows in L). The roof plate expression of Bmp4 in the normal control embryo is restricted to the regular domain (M, N), whereas expression is absent in the VAD control spinal cord as expected (O, arrows in P). Expression of Bmp4 in the roof plate resumes in the normal location in the VAD rescue embryo (Q, arrows in R).
in the dorsal domains of genes in the spinal cord (see Fig. 5 for summary). In addition, there is a loss of the V1 interneuron group and a disruption to the genes of the MN region. These data indicate a role for RA in repressing ventral neuronal genes and promoting the induction of dorsal genes (either directly or as a consequence of ventral repression), so that interneurons can develop in the centre of the spinal cord.
RA-deficiency causes disruptions to DV patterning genes specifically in the anterior spinal cord Although one of the proposed roles of RA in early neural patterning implies that RA acts throughout the AP extent of the neural tube through its posteriorising activity, recent experiments have suggested a more localised role of RA in the hindbrain and anterior spinal cord (reviewed in Liu et al., 2001; Maden, 2002) . Interestingly, during this study, observations on the AP variation of the DV phenotype in the absence of RA revealed that the majority of the disruptions to gene expression embryo spinal cord occurs in the anterior half of the spinal cord. This was the case with Shh (Figs. 2A , B, C), Nkx6.1, En-1, Bmp4, Bmp7, Msx2, Wnt1, Wnt3a, Pax3 (Figs. 2D, E, F) , and Pax7. In these embryos, the anterior extent of the DV phenotype was restricted to the hindbrain/spinal cord boundary and had a variable posterior limit, which extended in some cases to the caudal-thoracic level at its maximum length. However, some of the genes tested (including Pax6 and Cyp26A1) displayed the same DV phenotype down the whole AP axis, suggesting that RA exerts selective control over DV pattern, sometimes globally and sometimes locally.
Rescue of DV gene expression in the VAD spinal cord
Previous studies have demonstrated that a single injection of retinol (the precursor of RA) before stage 8 rescued the morphological and gene expression abnormalities associated with hindbrain and cranial nerve development in the VAD embryo, and resulted in the embryo undergoing normal development (Gale et al., 1999) . To confirm that the alterations of gene expression observed here were specifically due to an absence of RA, we rescued VAD embryos and analysed the resulting gene expressions.
The expression patterns of three genes found to be affected in the VAD spinal cord, namely Nkx6.1 (Figs. 3A -F), Pax3 (Figs. 3G -L), and Bmp4 (Figs. 3M -R), were tested in rescue embryos and were found to match the expression patterns associated with normal embryos. Control injections (Figs. 3C, D ; I, J and O, P) and injection of the retinol solution into normal embryos (Figs. 3A, B ; G, H, and M, N) had no effect on the expression patterns of genes normally associated with these embryos. 
Isolating novel RA-regulated genes
To further investigate the genetic disruptions observed in the VAD spinal cord, we performed a differential display reverse transcription PCR screen between normal and VAD spinal cords. This methodology allows the simultaneous detection of both up-and downregulated transcripts in response to retinoid deprivation. Thus, any changes ob- served between the normal and VAD profiles of gene expression in the spinal cord potentially lead to the isolation and identification of RA-regulated genes.
A total of 27 cDNAs (named A -Z, and g) were identified using 17 different primer combinations (Table 1) . Of these, 20 were selected from an upregulation and 7 due to a downregulation in the VAD spinal cord (see Figs. 4A and F for examples). However, it should be noted that the majority of transcripts (>95%) sampled by the screen did not show an altered level of gene expression in the VAD spinal cord compared to the normal, as represented by bands of similar intensity between normal and VAD lanes (Fig. 4) . This demonstrates that the <5% of differentially expressed transcripts identified in this screen reflects the specific and defined nature of spinal cord RA-responsive genes isolated in this manner.
The identities of the isolated cDNA fragments were revealed by either BLASTN or BLASTX searches of the sequences submitted in either BBSRC/UMIST chicken EST repository [http://www.chick.umist.ac.uk/] or the non-redundant Genbank database [http://www.ncbi.nlm.nih.gov/ BLAST/] (Table 1) . Of these sequences, 17 were shown to represent the quail orthologue (where identities range from eÀ 12 to eÀ 148 ) of previously described or hypothetically annotated proteins. Of the remaining 10 cDNAs, four had orthologous ESTs in the chick database but no functional annotation and six were not significantly similar to any sequence yet deposited. These latter 10 cDNAs may represent novel cDNAs or sequences for 3Vuntranslated regions of known genes (UTR) that are not described in the databases. The cDNAs identified can be functionally classified into groups and include molecules involved in signal transduction (e.g., RAC serine/threonine kinase), translational regulation (EIF P167), DNA binding (e.g., enhancer of splitrelated protein 7 (Hes)), metabolic control (cytochrome c oxidase), protein modification and trafficking (e.g., methylases and endosomal protein, respectively) as well as neurotransmitter phenotype (GABA(A) receptor) ( Table 1) .
Using the methodologically stringent approach applied here and described previously Medhurst et al., 2000) , it can be expected that each cDNA represents a real change in gene expression in the spinal cord in response to RA deprivation. In support of this, the reproducibility of each differential display gel profile was confirmed on independent normal and VAD spinal cord RNA samples (data not shown). These parameters have been shown to completely eliminate the occurrence of 'false positives'. To further confirm this, we selected an up-and downregulated clone for analysis by in situ hybridisation. Thus, the distribution and expression levels of clone groups W and Y were analysed in both normal and VAD embryos (Fig. 4) .
Clone W, previously annotated as hypothetical protein (Table 1) , was most highly expressed in the dorsal third of the normal spinal cord, in cells spanning the ventricular and mantle zones and including the roof plate domain (Figs. 4B and C). In agreement with the DD gel profile, transcripts representing clone W were also detected in the VAD spinal cord but at a much higher level and showing a dorsal to ventral expansion of the expression domain (Figs. 4D and  E) . The relative increase in expression of clone W was also reflected by the fact that it was isolated four times independently within the context of this screen. The dramatic increase in expression recorded for clone W in the VAD spinal cord prompted us to pursue a potential functional role for this cDNA. Sequence analysis of clone W cDNA indicated that it was the quail orthologue of an annotated human protein listed by IMAGE consortium as 3611719. Bio-informatic analysis of the 3611719 sequence (SwissProt Q9BTP1) using the NCBI Conserved Domain Search (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) reveals the presence of two well-conserved functional motifs (Fig. 4K) . Most notably the putative N-terminal region of 3611719 contains an extremely well-conserved chromatin organisation modifier (Chromo) domain (Fig. 4L) . Proteins containing Chromo domains have been shown to be powerful upstream regulators of gene expression (Cavalli and Paro, 1998) . In addition, there is evidence of a large Ankyrin repeat region within 3611719, a motif associated with protein -protein interactions. The data therefore suggest that 3611719, and its quail orthologue clone W, is a potentiator/regulator of chromatin structure and hence gene expression.
Correlating with the DD gel profile, whole mount in situ hybridisation of clone Y, a quail endosomal protein orthologue ( Table 1 ), showed that expression was significantly reduced in abundance in the VAD embryo. In the normal spinal cord, expression was restricted to the dorsal interneuron region and was absent from the roof plate, whereas expression in the VAD exhibited a strong downregulation in these regions. Similarity searches for the clone Y cDNA sequence show it to represent the quail orthologue of a human endosomal protein [Genbank S442443, 3e-21] (Table 1) .
Discussion
A role for RA in the DV patterning of the spinal cord
The data presented here implicate a role for RA in the regulation of patterning genes within the spinal cord region of the neural tube (Figs. 5 and 6 for summaries). In the absence of RA, there is a general dorsal expansion of ventrally restricted genes accompanied by a reduction in the domains of dorsally located genes (Fig. 5) . One explanation for such a phenotype lies in the molecular interactions that are a downstream consequence of altered Shh signalling: its dorsal expansion in the VAD resulting in a corresponding expansion of those genes that are positively regulated by SHH (Briscoe and Ericson, 2001) . Such an effect is reflected in the expression of the class II gene Nkx6.1 (Sander et al., 2000; Vallstedt et al., 2001) in the VAD spinal cord, where there is an expansion into prospective V1, V0 and dorsal domains. Likewise, a dorsal spread of SHH would also cause a reduction in the expression of those downstream genes that are negatively regulated by SHH, including class I genes such as Pax6 (Burrill et al., Fig. 6 . Summary of the proposed roles of RA in the DV patterning of the spinal cord. 1997; Ericson et al., 1997b; Lee and Pfaff, 2001 ). We observed a strong downregulation of Pax6 in the VAD embryo, although the domains of expression appear to remain normal, and a significant spatial reduction in the expression of other dorsal patterning genes, such as the Bmp genes. Interestingly, the regulation of Shh expression by RA must be tissue-specific. Here in the VAD neural tube, the Shh domain is expanded, but in the limb buds of VAD embryos Shh is absent (Stratford et al., 1999) .
In addition to the downregulation of Shh it is likely that class I and class II factors that display cross-repressive actions upon one another may provide a further effect on the patterning of the VAD spinal cord. For example, the reason for the dorsal expansion of Nkx6.1 may be 2-fold; firstly, there is the activation of expression by SHH, and secondly, there may be the release of the negative repression of the class I gene Dbx2. Although the expression of Dbx2 in the VAD spinal cord has not been tested in this current study, we would predict a downregulation of this gene in V0 and V1 interneuron populations in the absence of RA. Indeed, previous experiments have illustrated the existence of a SHH-independent, retinoid-activated pathway of neurogenesis in the V0 and V1 interneuron populations of the ventral spinal cord via the action of the Dbx1 and Dbx2 transcription factors (Pierani et al., 1999; 2001) . This finding is supported by the loss of the V1-specific expression of En-1 in the absence of RA in the current study and by data demonstrating the induction of ventral interneuron populations in both the chick spinal cord and in vitro (Renoncourt et al., 1998; Shiga et al., 1995) . Thus, RA is likely to be acting via more than one pathway to control DV patterning in the spinal cord.
The decrease in the intensity and ventricular zone expression of Isl-1 and MNR2 in the VAD provides evidence that RA is involved in the maintenance and spatial regulation of the expression domains of these MN genes and may reflect a decrease in the specification of MN subtype progenitors for which RA has been shown to be required, via the action of Raldh2 (Sockanathan and Jessell, 1998) . Therefore, we postulate that the decrease in MN gene expression points towards the partial or complete lack of specification of the prospective RA-dependent MN subtype (LMC L ) progenitors caused by a deficiency of RA. In vitro data also indicate that RA may act as an upstream regulator of MN patterning genes (Renoncourt et al., 1998) .
Given the gene expression phenotype observed in the VAD, one interpretation could entail the possibility that RA acts upstream of SHH in a manner that provides a broad prepattern to the DV axis of the spinal cord, which is then subsequently elaborated and refined by graded SHH signalling. Such a mechanism would provide an explanation for the broad DV patterning changes observed in the absence of RA, especially given recent data indicating Shh-independent mechanisms of patterning in the ventral neural tube (Litingtung and Chiang, 2000).
Integrating DV and AP patterning: clues from the VAD model
The finding that the majority of the disruptions to DV patterning genes occurs in the rostral domain of the spinal cord raises the question of the underlying nature of AP regional variation within the DV pattern of the spinal cord. Previous studies investigating the AP variations in DV patterning have concentrated on the specification of MNs at brachial and lumbar levels due to the variation in MN subtype between limb and non-limb levels. However, our data suggest that an additional level of molecular integration exists between the AP and DV axes that functions to broadly subdivide the spinal cord into anterior and posterior domains. Presumably this is a consequence of the sequential activation and spatiotemporal restriction of Hox genes (reviewed in Carpenter, 2002; Krumlauf, 1994) of which RA has been shown to be a modulator via functional RAREs (Gavalas, 2002; Gavalas and Krumlauf, 2000; Krumlauf, 1994; Marshall et al., 1996) . Specifically, evidence supporting a requirement for retinoid signalling in the control of anterior-specific function and expression of Hox genes is provided by experiments involving members of the Hox-c (Liu et al., 2001) , Hox-b (Bel-Vialar et al., 2002; Oosterveen et al., 2003) , and Hox-d (Nolte et al., 2003; Zhang et al., 1997 Zhang et al., , 2000 families of Hox genes. Our data on the anteriorspecific role of RA in patterning the spinal cord is also supported by the zebrafish neckless mutation (a Raldh2 mutation) where expression of ventral interneuron genes is lost specifically from the anterior spinal cord (Begemann et al., 2001 ).
Sources of RA in the neural tube
Where does the RA which provides this anterior-specific DV information originate? The usual assumption is that the adjacent somites provide a source of RA. Mesoderm-derived signals have been shown to play important roles in the patterning of neural tissue and retinoids are to be associated with several of these patterning events (Ensini et al., 1998; Gould et al., 1998; Itasaki et al., 1996; Muhr et al., 1999) , and at the caudal end of the embryo, somite-derived RA and tail bud-derived FGF play mutually antagonistic roles in the induction of neural differentiation (Diez del Corral et al., 2003) . However, neither of these sources are specific to the anterior spinal cord where alteration in DV pattern takes place.
Within the spinal cord RA is synthesised in the roof plate and in MN regions as indicated by the expression of Raldh2 (Berggren et al., 1999) , and in a ventral interneuron domain as suggested by the recently proposed novel RA-synthesising enzyme (Mic et al., 2002; Niederreither et al., 2002) . These intra-spinal cord enzyme expressions are, together, much more likely to provide a source of RA for the proposed DV patterning activities. In addition, the dorsal expression of Cyp26A1 provides a complementary region of RA catabolism that acts to provide a RA-free zone adjacent to regions of RA synthesis, thus forming a source and sink scenario similar to models proposed for the distribution of RA metabolising enzymes earlier in development (Maden, 1999; Mic et al., 2002; Swindell et al., 1999) . But again, these localisations are not restricted to the anterior spinal cord, so the complete picture of the origin of the RA required for DV patterning must await further studies.
Novel RA-regulated genes in the spinal cord To increase our existing knowledge of genes affected in the absence of retinoids, the differential display screen applied here has lead to the identification of a further 27 cDNAs that are regulated either positively or negatively by the absence of RA. Importantly, the analysis of the entire differential display data set reveals that the majority of transcripts observed in the normal and VAD spinal cord are not altered in their expression levels relative to each other. This demonstrates that RA regulates a discrete set of genes during the patterning of the DV axis and that the absence of RA leads to very specific perturbations in neuronal genes.
The wide variety of functional classes of transcripts isolated in response to an absence of RA (Table 1) in this screen reflect the diverse spectrum of known RA-mediated developmental cellular processes (reviewed in Maden, 2001) . Further detailed analysis of the biological functions of the clones isolated reveals incidences of coordinated changes in gene expression of functionally interconnected molecules. For example, qP-Rex1 (clone M), a known activator of RAC signalling molecules (Weiner, 2002) , is upregulated in the VAD spinal cord along with a simultaneous upregulation of a RAC serine/threonine kinase (clone B). Interestingly, actin polymerisation, which is markedly disrupted in the VAD spinal cord (Wilson et al., 2003) is known to be a direct target of RAC activity (e.g., (Sepp and Auld, 2003) ). Similarly, in the absence of retinoid signalling, there is a clear reproducible upregulation of transcription of a Hes-related protein (clone C). Proteins of this particular family are generally used as negative regulators of neuronal differentiation, thus, the upregulation of such a transcription factor in the VAD is consistent with the lower level of neuronal differentiation reported in the VAD quail CNS (Wilson et al., 2003) . In fact, members of the Hes family (Hes1) of transcription factors have been demonstrated to negatively regulate markers of differentiated neural phenotype such as a GABA-ergic phenotype (Kabos et al., 2002) . It is therefore of interest that clone L, a GABA(A) subunit, is downregulated in the VAD in contrast to the increased expression of clone C.
The localisation of clone Y (an endosomal protein) to the dorsal spinal cord indicates a possible function for this protein in this region of the neural tube, perhaps it highlights an increased requirement for endosomal activity in this region. Endosomes are membrane-bound organelles that are involved in many cellular processes from lysosomalmediated degradation to receptor-mediated internalisation. The latter function of endosomes is often employed as a mechanism by which a cell can regulate the extent of ligand/ receptor interaction and hence influence downstream signalling events and cellular responses (reviewed in Pfeffer, 2003) . Since band Y is downregulated in the dorsal neural tube in the VAD embryo and this correlates with the reduction in expression of molecules that signal via receptors such as RA, BMP4, BMP7, WNT1 and WNT3a (Fig. 1) , it is possible that this gene plays a role in signalling with these molecules. In addition, the enriched expression of endosomal protein in the ventricular zone provides potential for considering its role in cellular proliferation.
Thus, the identification of the set of RA-responsive genes described here gives us an opportunity to now functionally investigate and build a signalling network that underlies and interconnects the changes in gene expression and morphology associated with the VAD phenotype. In this manner, we hope to further piece together some of the gene regulatory networks operating in response to RA signalling during normal development.
